Kellie Murphy, MBA, is a BioPharma commercial strategy executive with over 21 years of experience in shaping strategies and driving successful launches across various sectors, including biotech startups and big pharma. Currently serving in US Rare Disease Access Strategy at Sanofi, Kellie has launched 17 new therapies and contributed to over 33 in-line brands, demonstrating a robust track record in market access, pricing, and reimbursement. With a commitment to improving patient access and an innovative approach to commercial strategies, Kellie is dedicated to accelerating healthcare advancements and enhancing patient lives. Education credentials include an MBA from Alvernia University and ongoing executive education at The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices